Labcorp Holdings Inc.
328.95USD
-0.9800 (-0.30%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on LH.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3,731 | 3,538 | 3,516 | 3,564 | 3,527 | 3,345 | 3,329 | 3,282 |
| Cost of Revenue | 2,619 | 2,524 | 2,523 | 2,538 | 2,481 | 2,397 | 2,433 | 2,378 |
| Gross Profit | 1,112 | 1,014 | 993 | 1,025 | 1,046 | 948 | 896 | 904 |
| Operating Income | 452 | 381 | 268 | 397 | 395 | 326 | 217 | 254 |
| Net Income | 299 | 278 | 165 | 261 | 238 | 213 | 143 | 169 |
| EPS (Diluted) | $3.64 | $3.35 | $1.98 | $3.12 | $2.84 | $2.52 | $1.71 | $2.00 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)